HomeBIAF • NASDAQ
add
bioAffinity Technologies Inc
Previous close
$2.79
Day range
$2.73 - $2.88
Year range
$0.95 - $3.62
Market cap
32.01M USD
Avg Volume
229.16K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 2.21M | 94,245.95% |
Operating expense | 2.89M | 77.80% |
Net income | -2.37M | -41.72% |
Net profit margin | -107.22 | 99.85% |
Earnings per share | — | — |
EBITDA | -2.07M | -27.77% |
Effective tax rate | -0.10% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 2.82M | -75.28% |
Total assets | 8.22M | -32.51% |
Total liabilities | 3.37M | 195.63% |
Total equity | 4.86M | — |
Shares outstanding | 11.51M | — |
Price to book | 5.37 | — |
Return on assets | -63.61% | — |
Return on capital | -77.49% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -2.37M | -41.72% |
Cash from operations | -1.62M | -24.27% |
Cash from investing | 13.44K | 106.11% |
Cash from financing | -84.80K | 84.95% |
Net change in cash | -1.69M | 19.02% |
Free cash flow | -326.76K | 64.36% |
About
Founded
2014
Headquarters
Website
Employees
75